KScan - Phosphoproteomic Diagnostic Platform

Kinomica have used KScan^®, a much more accurate way to predict whether an Acute myeloid leukaemia patient will respond to midostaurin. KScan^® involves measuring the simultaneous activity of kinases within a patient’s cancer cells. This readout can then better predict whether midostaurin will destroy those cells.